Hydreight Technologies Inc. Announces Strategic Acquisition of AI Asset
Hydreight Technologies Inc. (TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6) has signed a binding letter of intent with Auxano One LLC to acquire the Dynamic IV Therapy Support AI Agent, enhancing its mobile healthcare ecosystem. This AI clinical assistant analyzes patient data to provide personalized IV therapy recommendations, optimizing health outcomes. The acquisition includes a cash payment of $70,000 and potential equity issuance contingent upon business milestones totaling 175,000 shares. CEO Shane Madden emphasizes this integration will empower healthcare providers and enrich patient treatment plans. The global AI in healthcare market is expected to grow substantially, making this strategic move timely. The transaction is subject to regulatory approvals and is expected to form a comprehensive data and intelligence layer for personalized healthcare through Hydreight’s VSDHOne platform.
For more information, visit Hydreight’s website or reach out to their investor relations.
